EnBio Holdings, Inc (TYO:6092)

EnBio Holdings Revenue

In the fiscal year ending March 31, 2026, EnBio Holdings had annual revenue of 12.63B JPY with 18.39% growth. EnBio Holdings had revenue of 3.53B in the quarter ending March 31, 2026, with 42.46% growth.

• Revenue: 12.63B
• Revenue Growth: +18.39%
• P/S Ratio: 0.51
• Revenue / Employee: 125.05M
• Employees: 101
• Market Cap: 6.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	12.63B	1.96B	18.39%
Mar 31, 2025	10.67B	1.09B	11.42%
Mar 31, 2024	9.58B	1.46B	17.92%
Mar 31, 2023	8.12B	-867.00M	-9.65%
Mar 31, 2022	8.99B	2.15B	31.39%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error